- Home
- TT vs BMY Comparison
TT vs BMY Comparison
Compare TT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TT | BMY |
|---|---|---|
| Founded | 1885 | 1887 |
| Country | Ireland | United States |
| Employees | N/A | 32500 |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.0B | 113.5B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | TT | BMY |
|---|---|---|
| Price | $486.72 | $63.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $489.38 | $61.73 |
| AVG Volume (30 Days) | 1.3M | ★ 12.2M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 0.88% | ★ 4.38% |
| EPS Growth | ★ 15.48 | N/A |
| EPS | ★ 6.78 | N/A |
| Revenue | ★ $14,782,000,000.00 | N/A |
| Revenue This Year | $12.12 | N/A |
| Revenue Next Year | $8.06 | N/A |
| P/E Ratio | $69.65 | ★ $17.26 |
| Revenue Growth | ★ 5.58 | N/A |
| 52 Week Low | $348.06 | $42.52 |
| 52 Week High | $505.87 | $68.10 |
Technical Indicators
Market Signals| Indicator | TT | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 60.81 |
| Support Level | $462.60 | $53.81 |
| Resistance Level | $497.16 | N/A |
| Average True Range (ATR) | 15.86 | 1.87 |
| MACD | 0.48 | 0.27 |
| Stochastic Oscillator | 98.83 | 47.65 |
Price Performance
Historical ComparisonAbout TT Trane Technologies plc
Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The company generates approximately 70% of sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for approximately 80% of its revenue, with 13% from EMEA and 7% Asia-Pacific. The company was formed in 2020 when its former parent, Ingersoll Rand, merged with Gardner Denver in a tax-advantaged reverse Morris trust transaction.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.